| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |